Short Sellers Grow More Selective on Major Semiconductors
The August 15 short interest data have been compared with the previous report. Short interest moves were mixed in these selected semiconductor stocks.
All Work
Chris Lange
Short Sellers Can’t Make Up Their Minds on Major Biotechs
The August 15 short interest data have been compared with the previous report, and short interest moves in the selected biotech stocks were mixed.
Major Oil Short Interest Backs Off
The August 15 short interest data have been compared with the previous figures, and short interest moves for most of the selected oil stocks were downward.
Short Sellers Run for Cover From Major Pharma
The August 15 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks dropped.
Telsa Short Interest Inches Up on Model 3 Offering
In the most recent short interest report, Tesla saw the number of its shares short rise roughly 2% to more than 28 million.
Apple Short Interest Little Changed Ahead of iPhone 8 Release
Apple shares, although close to an all-time high, have only pushed higher by about 4% in just the past month. The most recent short interest report showed Apple shares short dropping about 3% to…
Thursday’s Biggest Winners and Losers in the S&P 500
Thursday was a relatively flat day for the U.S. broad markets. Both crude oil and gold dipped lower for the day but there wasn’t any major fallout. Out of the S&P 500 sectors only…
What to Expect When GameStop Reports After the Close
This stock might have lulled many investors to sleep, but with retailers making a stand in August after a lackluster year GameStop might be poised to break out.
Why Michaels Is One of Thursday’s Top Performing Retailers
Michaels Companies released a better-than-expected fiscal second-quarter earnings report before the markets opened on Thursday.
Is This the Turnaround Signet Jewelers Has Waited For?
Signet Jewelers had been tanking in 2017, with shares down over 40%. However, with this earnings report and an acquisition, it could be staging a big turnaround.
Dollar Tree Another Bright Spot in the Retail Gloom
Dollar Tree released a better-than-expected quarterly report before the markets opened on Thursday.
Why Abercrombie & Fitch Won Big Despite a Q2 Loss
Abercrombie & Fitch reported better than expected fiscal second-quarter financial results before the markets opened on Thursday.
HP Earnings Beat Not Enough for Investors
HP Inc. (NYSE: HPQ) reported its fiscal third-quarter financial results after the markets closed on Wednesday. The firm said that it had $0.43 in earnings per share (EPS) on $13.1 billion in revenue, compared…
Wednesday’s Biggest Winners and Losers in the S&P 500
The U.S. broad markets backed off Wednesday after having one of the best trading days of the year on Tuesday. Crude oil was positive on the day and Oil & Gas stocks responded in…
Why Jefferies Sees Huge Upside in Fiat Chrysler
Shares of Fiat Chrysler saw a handy gain on Wednesday after the auto manufacturer received the nod from a key analyst. This comes after the company has reportedly been in talks with a Chinese…
What to Expect When HP Reports After the Close
Since the company split in late 2015, HP has made solid gains, although it did take a dip first. The upcoming earnings report could set the stage for the company to continue pushing its…
What Analysts Are Saying About Salesforce After Earnings
Salesforce.com released its most recent earnings report late Tuesday, and analysts overall responded positively.
Why American Eagle Outfitters Is Bucking the Retail Trend
It seems that this retailer was able to buck the trend with these most recent results, and on the back of solid comparable sales.
Ultragenyx Stumbles Over Late-Stage Trial
Ultragenyx Pharmaceutical shares took a turn for the worse on Wednesday after a report that results from its late-stage trial did not live up to expectations.
Intra-Cellular Soars on Critical FDA Update
Intra-Cellular Therapies saw its shares make an incredible gain early on Wednesday after the FDA gave a positive regulatory update on the firm’s schizophrenia program.